|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01548 GENSCRIPT BIO
Nominal 
33.360 +4.000 (+13.624%) | 2026/06 - Interim USD(K$) | %Chg (Compare to Interim) | 2025/06 USD(K$) | 2024/06 USD(K$) | 2023/06 USD(K$) | 2022/06 USD(K$) | |
| Turnover | 404,216 | -22.082% | 518,773 | 561,371 | 391,311 | 309,589 |
| Cost of Sales | (197,505) | -0.321% | (198,142) | (254,385) | (216,263) | (141,091) |
| Gross Profit | 206,711 | -35.530% | 320,631 | 306,986 | 175,048 | 168,498 |
| 2026/06 - Interim USD(K$) | %Chg (Compare to Interim) | 2025/06 USD(K$) | 2024/06 USD(K$) | 2023/06 USD(K$) | 2022/06 USD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (7,820) | -41.493% | (13,366) | (154,852) | (37,098) | (47,359) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (154,959) | -19.879% | (193,406) | 0 | (230) | 0 | |
| Profit / (Loss) before Taxation | (119,417) | 100250.420% | (119) | (205,588) | (244,653) | (229,776) | |
| Taxation | (9,927) | -59.362% | (24,428) | (10,043) | (1,104) | (3,813) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 1 | -- | (915) | 40,516 | 152,176 | 98,082 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (129,343) | 407.984% | (25,462) | (175,115) | (93,581) | (135,507) | |
| 2026/06 - Interim USD(K$) | %Chg (Compare to Interim) | 2025/06 USD(K$) | 2024/06 USD(K$) | 2023/06 USD(K$) | 2022/06 USD(K$) | |
| Net Finance Costs / (Income) | (1,531) | -- | 576 | 14,226 | (12,403) | 84 |
| Depreciation & Amortisation | 40,420 | 15.843% | 34,892 | 40,295 | 35,522 | 30,020 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | -5.920 | 401.695% | -1.180 | -8.270 | -4.440 | -6.480 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 1.776 | -- | 2.026 | 0.571 | 0.639 | -- |
| Remarks: | Real time quote last updated: 20/08/2026 16:48 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | USD -129,343 |
| %Change | 407.984% |
| EPS / (LPS) | USD -0.059 |
| NBV Per Share ($) | USD 1.776 |